Stock Updates

How has Fresenius Medical Care AG & Co. KGAA:(NYSE:FMS) performed recently?

Fresenius Medical Care AG & Co. KGAA (NYSE: FMS) is a large market cap stock with a market cap of 28536.01. It is in the Specialized Health Services industry and sector Healthcare, with a current P/E of 26.9, a forward P/E of 20.05 and EPS of 1.72. At a stock price of 45.69 (-1.06%) it has a dividend yield of 0.97%.

EPS growth for the last five years have been 15.90%, more recently this last year it has grown by -2.00%. The next year growth is going to be about 13.39% and more long-term 9.55% after five years. EPS growth quarter over quarter is 8.50%. Sales growth for the past five years have been 7.20% and sales growth quarter over quarter is 6.20%.

For performance, Fresenius Medical Care AG & Co. KGAA the past week has seen a gain of 2.94%. For the last month performance for Fresenius Medical Care AG & Co. KGAA is 6.21%. While the last quarter is 6.68% and half year, 3.95%. Finally for the year, performance is 11.21%.

The 52-week high for Fresenius Medical Care AG & Co. KGAA, is at -2.10%, and for the 52-week low it comes to a value of 25.12%. The 20-day simple moving average is 5.66% and 7.47% for the 200-day simple moving average.

Volatility for the week is at 0.95%, and for the month it is 0.89%. Fresenius Medical Care AG & Co. KGAA, has a target price of 47.9.

In terms of debt, long term debt/equity is 0.77, and for total debt/equity Fresenius Medical Care AG & Co. KGAA has 0.88. The gross margin is 32.20%, while operating margin is 13.90%, the profit margin is 6.20%. The current ratio is 1.6 and the quick ratio is 1.3.

Insider ownership is at 35.70%, with instituitional ownership at 2.30%. Fresenius Medical Care AG & Co. KGAA has a payout ratio of 25.30%. With the total shares outstanding coming to 617.93. The shares float is 615.34, with the float short at 0.13%, with short ratio coming to 4.81.

In terms of returns, the return on assets see Fresenius Medical Care AG & Co. KGAA, get 4.10%, with its returns on investment at 9.10%. Return on equity is 10.70%. So will the investors see the target price of 47.9, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

 

About the author

Stephen Butters

Leave a Comment